(PharmaNewsWire.Com, December 16, 2017 ) Of all the cancers, lung cancer is the second most common and causes the largest number of deaths. Pollution in general and cigarette smoking specifically is the cause for lung cancer market. It deteriorates lungs to such an extent that they can no longer deliver oxygen to the blood stream.
Lung Cancer Therapeutics Market: Drivers & Restraints Rising number of cases of people who smoke is the primary driver of this market. Other than that advent of advanced drugs and new radiation therapies are secondary factors driving the market.
Generalization of drugs is the major hindrance to market growth.
• Chemotherapy o Cisplatin o Taxol o Navelbine o Camptosar o Alimta
• Radiotherapy o External Beam o Internal Beam o Systemic
• Other Drugs o Abraxane o Avastin o Crizotinib o Docetaxel o Gefitinib
By Geography • Europe o U.K o Spain o Germany o Italy o France From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization.
Lung Cancer Therapeutics Market: Overview In 2017, chemotherapy was the market leader and is predicted to remain so in the aforementioned forecast period.
As of 2017, Europe held the second largest share of the Lung Cancer Therapeutics Market. Rising number of cases of lung cancer in developing countries like India and China makes it Asia Pacific the fastest growing market in the forecast period.
Lung Cancer Therapeutics Market: Key Players
Some of the major players competing in the European market are GmbH, Hoffman-La Roche, Pfizer Inc., GlaxoSmitKline, Eli Lilly and Company, Agennix AG, AstrazenecaPlc, and Sanofi-Aventis.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
